These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 3040881)
1. Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. Buckingham JC J Endocrinol; 1987 Jun; 113(3):389-96. PubMed ID: 3040881 [TBL] [Abstract][Full Text] [Related]
2. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA Peptides; 1984; 5(3):519-22. PubMed ID: 6089144 [TBL] [Abstract][Full Text] [Related]
3. A novel type of vasopressin receptor on anterior pituitary corticotrophs? Baertschi AJ; Friedli M Endocrinology; 1985 Feb; 116(2):499-502. PubMed ID: 2981663 [TBL] [Abstract][Full Text] [Related]
4. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Rivier C; Rivier J; Mormede P; Vale W Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290 [TBL] [Abstract][Full Text] [Related]
5. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary. Pierson PM; Guibbolini ME; Lahlou B J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs. Knepel W; Homolka L; Vlaskovska M; Nutto D Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345 [TBL] [Abstract][Full Text] [Related]
7. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Schlosser SF; Almeida OF; Patchev VK; Yassouridis A; Elands J Endocrinology; 1994 Nov; 135(5):2058-63. PubMed ID: 7956927 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the dual mechanism of ACTH release by arginine vasopressin and its analogs in conscious rats. Mormède P; LeMoal M; Dantzer R Regul Pept; 1985 Nov; 12(3):175-84. PubMed ID: 3001841 [TBL] [Abstract][Full Text] [Related]
9. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of the ACTH response to repeated pulses of corticotrophin-releasing factor and arginine vasopressin in vitro. Evans MJ; Brett JT; McIntosh RP; McIntosh JE; McLay JL; Livesey JH; Donald RA J Endocrinol; 1988 Jun; 117(3):387-95. PubMed ID: 2839591 [TBL] [Abstract][Full Text] [Related]
11. Gonadotrophin-releasing activity of neurohypophysial hormones: II. The pituitary oxytocin receptor mediating gonadotrophin release differs from that of corticotrophs. Evans JJ; Catt KJ J Endocrinol; 1989 Jul; 122(1):107-16. PubMed ID: 2475564 [TBL] [Abstract][Full Text] [Related]
12. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies. Familari M; Smith AI; Smith R; Funder JW Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836 [TBL] [Abstract][Full Text] [Related]
13. Involvement of vasopressin V1- and V2-receptors in histamine-and stress-induced secretion of ACTH and beta-endorphin. Kjaer A; Knigge U; Vilhardt H; Bach FW; Warberg J Neuroendocrinology; 1993 Mar; 57(3):503-9. PubMed ID: 8391663 [TBL] [Abstract][Full Text] [Related]
14. Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin. Gibbs DM; Vale W; Rivier J; Yen SS Life Sci; 1984 Jun; 34(23):2245-9. PubMed ID: 6328161 [TBL] [Abstract][Full Text] [Related]
15. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion. Labrie F; Giguere V; Proulx L; Lefevre G J Steroid Biochem; 1984 Jan; 20(1):153-60. PubMed ID: 6323861 [TBL] [Abstract][Full Text] [Related]
16. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. Calogero AE; Bagdy G; Moncada ML; D'Agata R J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213 [TBL] [Abstract][Full Text] [Related]
17. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737 [TBL] [Abstract][Full Text] [Related]
18. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812 [TBL] [Abstract][Full Text] [Related]
19. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors. Koch B; Lutz-Bucher B Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673 [TBL] [Abstract][Full Text] [Related]
20. Effects of corticotrophin-releasing factor and arginine-vasopressin on proopiomelanocortin (POMC) mRNA levels, release and storage of adrenocorticotrophin from mouse anterior pituitary cells. Castro MG Comp Biochem Physiol Comp Physiol; 1993 Jan; 104(1):105-12. PubMed ID: 8094652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]